Live Breaking News & Updates on Division Of Gynecology Oncology

Stay updated with breaking news from Division of gynecology oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a ...

First-in-class macrocyclic ATR inhibitor, ATRN-119, on track to complete dose escalation and potentially generate human efficacy data in H2 2024 ....

United States , University Of Pennsylvania , Nadeem Mirza , Oren Gilad , Timothy Yap , Eric Brown , Fiona Simpkins , Mike Moyer , American Association Of Cancer Research , Securities Exchange , Atrin Pharmaceuticals Inc , Exchange Commission , Abramson Family Cancer Research Institute , University Of Texas Md Anderson Cancer Center , Division Of Gynecology Oncology , Aprea Therapeutics Inc , Chief Executive Officer , Business Updates , Potential Upcoming Key , American Association , Cancer Research , Investigational New Drug , Key Opinion Leader , Synthetic Lethality , Key Opinion Leaders , Gynecology Oncology ,

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , University Of Pennsylvania , Timothy Yap , Eric Brown , Oren Gilad , Mike Moyer , Fiona Simpkins , Nadeem Mirza , Division Of Gynecology Oncology , American Association Of Cancer Research , Atrin Pharmaceuticals Inc , Securities Exchange , Center Evaluation , Exchange Commission , Aprea Therapeutics Inc , Abramson Family Cancer Research Institute , University Of Texas Md Anderson Cancer Center , Chief Executive Officer , Business Updates , Potential Upcoming Key , American Association , Cancer Research , Investigational New Drug , Multi Center Evaluation , Solid Tumors , Key Opinion Leader ,

2023-10-24 | NDAQ:APRE | Press Release | Aprea Therapeutics Inc

(2023-10-24 | NDAQ:APRE) Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways ....

United Kingdom , City Of , United States , University Of Pennsylvania , Aprea Closecurlyquote , Fiona Simpkins , Yap Closecurlyquote , Aprea Closecurlydoublequote , Timothy Yap , Mike Moyer , Timothya Yap , Securities Exchange , Cleveland Clinic Foundation , Johns Hopkins University , Translational Research , Exchange Commission , Therapeutics Discovery Division , Institute Of Cancer Research , Aprea Therapeutics Inc , National Institute For Health Research , Perelman School Of Medicine , Cancer Research Training , Department Of Thoracic Head , Division Of Gynecology Oncology , National Cancer Institute , Company Closecurlyquote ,

Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways

Event featuring Fiona Simpkins, M.D. and Timothy A. Yap, MBBS, PhD, FRCP to take place on October 31, 2023 at 11:00 am ETDOYLESTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced it will host a KOL event on Tuesday, October 31, 2023 at 11:00 am ET. The program will feature Dr. Fiona Simpkins, Perelman School of Medicin ....

United States , United Kingdom , University Of Pennsylvania , City Of , Fiona Simpkins , Timothy Yap , Timothya Yap , Perelman School Of Medicine , Johns Hopkins University , National Cancer Institute , Head Of Clinical Development , Securities Exchange , Exchange Commission , National Institute For Health Research , University Of Texas Md Anderson Cancer Center , Cleveland Clinic Foundation , Institute Of Cancer Research , Aprea Therapeutics Inc , Cooperative Group , University Of Miami , Institute For Personalized Cancer Therapy , Division Of Gynecology Oncology , Therapeutics Discovery Division , Department Of Thoracic Head , Translational Research , Cancer Research Training ,

Aprea Therapeutics to Host a Key Opinion Leader (KOL) Event on its Synthetic Lethality (SL) and DNA Damage Response (DDR) Pathways - Aprea Therapeutics (NASDAQ:APRE)

DOYLESTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical stage biopharmaceutical company focused on precision oncology through synthetic ....

City Of , United Kingdom , United States , University Of Pennsylvania , Fiona Simpkins , Timothy Yap , Timothya Yap , Mike Moyer , National Institute For Health Research , Johns Hopkins University , Exchange Commission , Department Of Thoracic Head , Head Of Clinical Development , Institute For Personalized Cancer Therapy , Therapeutics Discovery Division , Cancer Research Training , University Of Texas Md Anderson Cancer Center , Institute Of Cancer Research , Perelman School Of Medicine , Division Of Gynecology Oncology , University Of Miami , National Cancer Institute , Cleveland Clinic Foundation , Translational Research , Aprea Therapeutics Inc , Securities Exchange ,